Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference25 articles.
1. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010
2. [accessed Jun 2011].
3. SEOM clinical guidelines for the treatment of invasive bladder cancer;Morales;Clin Trans Oncol,2011
4. Overview of bladder cancer trials in the European Organization for Research and Treatment;de Wit;Cancer,2003
5. Treatment of patients with metastatic urothelial cancer “unfit” for Cisplatin-based chemotherapy;Galsky;J Clin Oncol,2011
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis;Clinical Genitourinary Cancer;2024-12
2. Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma;The Oncologist;2024-08-21
3. Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study;Medical Oncology;2024-08-06
4. Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy;The Oncologist;2024-07-02
5. A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma;Targeted Oncology;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3